Changes

Jump to navigation Jump to search
209 bytes added ,  04:03, November 16, 2021
Daniel Horowitz explained in a detailed article that "Remdesivir is the greatest scandal of the pandemic."
Line 2: Line 2:  
[[File:Fauci.PNG|right|225px|thumb|Anthony Fauci]]
 
[[File:Fauci.PNG|right|225px|thumb|Anthony Fauci]]
 
As of November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>
 
As of November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>
 +
 +
Daniel Horowitz explained in a detailed article that "Remdesivir is the greatest scandal of the pandemic."<ref>https://www.theblaze.com/op-ed/horowitz-remdesivir-is-the-greatest-scandal-of-the-pandemic</ref>
    
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment.  But hospitals receive special financial incentives to administer remdesivir despite its ineffectiveness.<ref>"CMS in October announced interim add-on payments for COVID-19 treatments including remdesivir through the HHS-declared public health emergency. The declaration next expires in January, though stakeholders think it’s likely the emergency will be renewed." [https://medlancr.com/gilead-applied-for-hospital-add-on-payment-for-remdesivir/]</ref>
 
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment.  But hospitals receive special financial incentives to administer remdesivir despite its ineffectiveness.<ref>"CMS in October announced interim add-on payments for COVID-19 treatments including remdesivir through the HHS-declared public health emergency. The declaration next expires in January, though stakeholders think it’s likely the emergency will be renewed." [https://medlancr.com/gilead-applied-for-hospital-add-on-payment-for-remdesivir/]</ref>
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,204

edits

Navigation menu